15-PGDH inhibition activates the splenic niche to promote hematopoietic regeneration is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 21 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health (NIH); Institute: National Cancer Institute
Grant: R35 CA197442
National Institute of Health (NIH); Institute: National Heart, Lung, and Blood Institute
Grant: K99 HL135740
National Institute of Health (NIH); Institute: National Institute of Biomedical Imaging and Bioengineering
Grant: T32 EB005583
National Institute of Health (NIH); Institute: National Cancer Institute
Grant: R01 CA216863
NHLBI NIH HHS
Grant: R00 HL135740
NCI NIH HHS
Grant: P30 CA043703
National Institutes of Health
Grant: 5R01CA216863-03
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation
National Institutes of Health
Grant: 5R35CA197442-07
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
National Institutes of Health
Grant: 5T32EB005583-09
Postdoctoral Training Program in Tissue Engineering and Biomaterials Science
National Institutes of Health
Grant: 1K99HL135740-01
Towards Improving Bone Marrow Transplantation via Inhibition of 15-PGDH
National Institutes of Health
Grant: 3P30CA043703-20S1
Case Comprehensive Cancer Center Support Grant
FWCI
1.70
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals